AU4425399A - Novel therapeutic agents that modulate 5-ht receptors - Google Patents
Novel therapeutic agents that modulate 5-ht receptorsInfo
- Publication number
- AU4425399A AU4425399A AU44253/99A AU4425399A AU4425399A AU 4425399 A AU4425399 A AU 4425399A AU 44253/99 A AU44253/99 A AU 44253/99A AU 4425399 A AU4425399 A AU 4425399A AU 4425399 A AU4425399 A AU 4425399A
- Authority
- AU
- Australia
- Prior art keywords
- modulate
- receptors
- therapeutic agents
- novel therapeutic
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 title 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8846698P | 1998-06-08 | 1998-06-08 | |
| US60088466 | 1998-06-08 | ||
| US9293898P | 1998-07-15 | 1998-07-15 | |
| US60092938 | 1998-07-15 | ||
| US9660698P | 1998-08-14 | 1998-08-14 | |
| US60096606 | 1998-08-14 | ||
| PCT/US1999/012751 WO1999064044A1 (en) | 1998-06-08 | 1999-06-07 | Novel therapeutic agents that modulate 5-ht receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4425399A true AU4425399A (en) | 1999-12-30 |
Family
ID=27375972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU44253/99A Abandoned AU4425399A (en) | 1998-06-08 | 1999-06-07 | Novel therapeutic agents that modulate 5-ht receptors |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1083918A1 (en) |
| AR (1) | AR019631A1 (en) |
| AU (1) | AU4425399A (en) |
| CA (1) | CA2319174A1 (en) |
| SG (1) | SG83723A1 (en) |
| WO (1) | WO1999064044A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9903996D0 (en) * | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
| DE10037310A1 (en) | 2000-07-28 | 2002-02-07 | Asta Medica Ag | New indole derivatives and their use as medicines |
| US6444477B1 (en) * | 2000-11-28 | 2002-09-03 | Pharmagene Laboratories Limited | Assay method for detecting 5-HT2B antagonists |
| WO2002060375A2 (en) * | 2001-01-29 | 2002-08-08 | Insight Strategy And Marketing Ltd | Diphenyl ether derivatives and their uses as heparanase inhibitors |
| AU2003297048A1 (en) * | 2002-12-13 | 2004-07-09 | Smithkline Beecham Corporation | Cyclohexyl compounds as ccr5 antagonists |
| CN102060806A (en) | 2003-09-11 | 2011-05-18 | iTherX药品公司 | Cytokine inhibitors |
| US7381732B2 (en) | 2004-10-26 | 2008-06-03 | Bristol-Myers Squibb Company | Pyrazolobenzamides and derivatives as factor Xa inhibitors |
| WO2010123139A1 (en) * | 2009-04-24 | 2010-10-28 | 持田製薬株式会社 | Arylcarboxamide derivative having sulfamoyl group |
| PT3027603T (en) * | 2013-08-02 | 2018-10-11 | Pfizer | Heterobicycloaryl rorc2 inhibitors and methods of use thereof |
| WO2016014797A1 (en) * | 2014-07-24 | 2016-01-28 | Sensor Pharmaceuticals, Inc. | Compositions and methods for targeting receptors expressed in the gut |
| CN105439914B (en) * | 2014-09-17 | 2017-07-11 | 复旦大学 | 4 aminoacyl phenoxy acetamide class compounds and its medicinal usage |
| EP3250561A1 (en) | 2015-01-30 | 2017-12-06 | Pfizer Inc | Sulfonamide-subsituted indole modulators of rorc2 and methods of use thereof |
| JP2018505878A (en) | 2015-01-30 | 2018-03-01 | ファイザー・インク | RORC2 methoxy-substituted pyrrolopyridine modulator and method of use thereof |
| CA3191095A1 (en) * | 2020-09-02 | 2022-03-10 | Enveric Biosciences Canada Inc. | Nitrated psilocybin derivatives and use thereof for modulating 5-ht2a receptor and for treating a psychiatric disorder |
| WO2023044556A1 (en) * | 2021-09-24 | 2023-03-30 | Enveric Biosciences Canada Inc. | Aminated psilocybin derivatives and methods of using |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8730691A (en) * | 1990-09-28 | 1992-04-28 | Neorx Corporation | Polymeric carriers for release of covalently linked agents |
| US5364856A (en) * | 1991-03-28 | 1994-11-15 | Eli Lilly And Company | 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles |
| US5244912A (en) * | 1991-03-28 | 1993-09-14 | Eli Lilly And Company | 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof |
| FR2712591B1 (en) * | 1993-11-19 | 1996-02-09 | Pf Medicament | New arylpiperazines derived from indole, their preparation and their therapeutic use. |
| GB9517559D0 (en) * | 1995-08-26 | 1995-10-25 | Smithkline Beecham Plc | Novel compounds |
| AU2332497A (en) * | 1996-03-19 | 1997-10-10 | Salk Institute For Biological Studies, The | (in vitro) methods for identifying modulators of members of the steroid/thyroid superfamily of receptors |
| US6500934B1 (en) * | 1996-07-24 | 2002-12-31 | Michael Rush Lerner | Bivalent agonists for G-protein coupled receptors |
| WO1998011436A1 (en) * | 1996-09-13 | 1998-03-19 | Whitehead Institute For Biomedical Research | Non-specific affinity enhancement to identify combinatorial library members |
| ZA9711376B (en) * | 1996-12-20 | 1998-07-21 | Lundbeck & Co As H | Indole or dihydroindole derivatives |
-
1999
- 1999-06-07 AU AU44253/99A patent/AU4425399A/en not_active Abandoned
- 1999-06-07 EP EP99927317A patent/EP1083918A1/en not_active Withdrawn
- 1999-06-07 WO PCT/US1999/012751 patent/WO1999064044A1/en not_active Application Discontinuation
- 1999-06-07 CA CA002319174A patent/CA2319174A1/en not_active Abandoned
- 1999-06-08 AR ARP990102708A patent/AR019631A1/en unknown
- 1999-06-08 SG SG9902842A patent/SG83723A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999064044A1 (en) | 1999-12-16 |
| EP1083918A1 (en) | 2001-03-21 |
| AR019631A1 (en) | 2002-02-27 |
| SG83723A1 (en) | 2001-10-16 |
| CA2319174A1 (en) | 1999-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4557099A (en) | Novel therapeutic agents that modulate estrogen receptors | |
| AU4674599A (en) | Novel therapeutic agents that modulate enzymatic processes | |
| AU4550699A (en) | Multibinding agents that modulate the 5-ht transporter | |
| AU4394799A (en) | Retinoid-associated receptor regulators | |
| AU4698299A (en) | 5-HT7 receptor antagonists | |
| AU4425399A (en) | Novel therapeutic agents that modulate 5-ht receptors | |
| AU6679296A (en) | Hepadnavirus receptor | |
| AU7132898A (en) | Edg-1-like receptor | |
| AU2001226387A1 (en) | Methods of identifying modulators of the fgf receptor | |
| AU1296899A (en) | Phenyl-alkyl-imidazoles as h3 receptor antagonists | |
| AU1535699A (en) | Novel receptors opg-2 | |
| AU7450898A (en) | Indole compounds | |
| AU1744700A (en) | Human neurotensin subtype 2 receptor | |
| AU3668499A (en) | Human receptor molecules | |
| AU6035398A (en) | Human c5a-like receptor | |
| AU4544099A (en) | Novel therapeutic agents for macromolecular structures | |
| AU7583898A (en) | Gdnf receptors | |
| AU1171099A (en) | Therapeutic agents | |
| AU6006399A (en) | Novel g protein-coupled receptors | |
| AU3543599A (en) | Receptors | |
| AU4262799A (en) | Tetraisoquinololine derivatives as modulators of dopamine d3 receptors | |
| AU6826498A (en) | Endotholin receptor antagonists | |
| AU5153099A (en) | Adjustable drum | |
| AUPP592298A0 (en) | Protease-activated receptors | |
| AUPP797698A0 (en) | Therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |